These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2850062)

  • 21. Prostacyclin generation by cultured human vascular endothelial cells with reference to angiotensin I-converting enzyme.
    Sawada S; Toyoda T; Takamatsu H; Niwa I; Maebo N; Tsuji H; Nakagawa M; Ijichi H
    Jpn Circ J; 1986 Mar; 50(3):242-7. PubMed ID: 3016357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture.
    Doni MG; Whittle BJ; Palmer RM; Moncada S
    Eur J Pharmacol; 1988 Jun; 151(1):19-25. PubMed ID: 3046956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelium-derived relaxing factor (EDRF) from cultured and fresh endothelial cells.
    Gryglewski RJ; Trybulec M; Radziszewski W; Swierkosz T; Dudek R; Zembowicz A
    Biomed Biochim Acta; 1988; 47(10-11):S61-6. PubMed ID: 2470361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACE inhibition enhances bradykinin relaxations through nitric oxide and B1 receptor activation in bovine coronary arteries.
    Gauthier KM; Cepura CJ; Campbell WB
    Biol Chem; 2013 Sep; 394(9):1205-12. PubMed ID: 23729620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.
    Wiemer G; Schölkens BA; Becker RH; Busse R
    Hypertension; 1991 Oct; 18(4):558-63. PubMed ID: 1655653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide modulates captopril-mediated angiotensin-converting enzyme inhibition in porcine iliac arteries.
    Persson K; Andersson RG
    Eur J Pharmacol; 1999 Nov; 385(1):21-7. PubMed ID: 10594341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-induced release of prostacyclin from perfused organs.
    Grodzińska L; Gryglewski RJ
    Pharmacol Res Commun; 1980 Apr; 12(4):339-47. PubMed ID: 6994129
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of endothelium-derived bradykinin in the control of vascular tone.
    Hecker M; Dambacher T; Busse R
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the release of vasoactive factors from venous and arterial bovine cultured endothelial cells.
    D'Orleans-Juste P; Mitchell JA; Wood EG; Hecker M; Vane JR
    Can J Physiol Pharmacol; 1992 May; 70(5):687-94. PubMed ID: 1423010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective inhibition of agonist-induced but not shear stress-dependent release of endothelial autacoids by thapsigargin.
    Macarthur H; Hecker M; Busse R; Vane JR
    Br J Pharmacol; 1993 Jan; 108(1):100-5. PubMed ID: 8428199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylene blue but not changes in cyclic GMP inhibits resting and bradykinin-stimulated production of prostacyclin by pig aortic endothelial cells.
    Martin W; Drazan KM; Newby AC
    Br J Pharmacol; 1989 May; 97(1):51-6. PubMed ID: 2541859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells.
    Martin W; White DG; Henderson AH
    Br J Pharmacol; 1988 Jan; 93(1):229-39. PubMed ID: 2894877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells.
    Kuhn M; Otten A; Frölich JC; Förstermann U
    J Pharmacol Exp Ther; 1991 Feb; 256(2):677-82. PubMed ID: 1847208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostacyclin mediates the potentiated hypotensive effect of bradykinin following captopril treatment.
    Mullane KM; Moncada S
    Eur J Pharmacol; 1980 Sep; 66(4):355-65. PubMed ID: 6998710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Nov; 92(3):639-46. PubMed ID: 3322462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pericardial release of prostacyclin induced by bradykinin and angiotensin II: effects on coronary blood flow in the dog.
    Woodman OL; Dusting GJ; Nolan RD
    J Cardiovasc Pharmacol; 1983; 5(6):954-60. PubMed ID: 6196567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery.
    Miyamoto A; Murata S; Nishio A
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):365-70. PubMed ID: 12012022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor.
    Zembowicz A; Swierkosz TA; Southan GJ; Hecker M; Vane JR
    Br J Pharmacol; 1992 Dec; 107(4):1001-7. PubMed ID: 1281716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle.
    Shikano K; Berkowitz BA
    J Pharmacol Exp Ther; 1987 Oct; 243(1):55-60. PubMed ID: 3499504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of SKF 525A on the release of nitric oxide and prostacyclin from endothelial cells.
    Rees DD; Palmer RM; Moncada S
    Eur J Pharmacol; 1988 May; 150(1-2):149-54. PubMed ID: 3136027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.